| 000 | 01814 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515000812.0 | ||
| 264 | 0 | _c20060329 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a1476-7120 | ||
| 024 | 7 |
_a10.1186/1476-7120-3-26 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJochmann, Nicoline | |
| 245 | 0 | 0 |
_aLong-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report. _h[electronic resource] |
| 260 |
_bCardiovascular ultrasound _cSep 2005 |
||
| 300 |
_a26 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _a3',5'-Cyclic-GMP Phosphodiesterases |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 5 |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xchemically induced |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPhosphoric Diester Hydrolases _xdrug effects |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 | _aPurines |
| 650 | 0 | 4 | _aSildenafil Citrate |
| 650 | 0 | 4 |
_aSulfones _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriazines _xadministration & dosage |
| 650 | 0 | 4 | _aVardenafil Dihydrochloride |
| 700 | 1 | _aKiecker, Felix | |
| 700 | 1 | _aBorges, Adrian C | |
| 700 | 1 | _aHofmann, Maja A | |
| 700 | 1 | _aEddicks, Stephan | |
| 700 | 1 | _aSterry, Wolfram | |
| 700 | 1 | _aBaumann, Gert | |
| 700 | 1 | _aTrefzer, Uwe | |
| 773 | 0 |
_tCardiovascular ultrasound _gvol. 3 _gp. 26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1476-7120-3-26 _zAvailable from publisher's website |
| 999 |
_c15774662 _d15774662 |
||